Paroxysmal nocturnal hemoglobinuria in pediatric patients

Pediatric Blood and Cancer

Volumn 59, Issue 3, 2012, Pages 525-529

  Curran, Kevin J ^a   Kernan, Nancy A ^a   Prockop, Susan E ^a   Scaradavou, Andromachi ^a   Small, Trudy N ^a   Kobos, Rachel ^a   Castro Malaspina, Hugo ^a   Araten, David ^b   Dimichele, Donna ^c,d   O'Reilly, Richard J ^a   Boulad, Farid ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Aplastic anemia; Hematopoietic stem cell transplantation; Myelodysplastic syndrome; Paroxysmal nocturnal hemoglobinuria; Pediatric

Indexed keywords

BILIRUBIN; CYCLOSPORIN A; ECULIZUMAB; LACTATE DEHYDROGENASE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BILIRUBIN BLOOD LEVEL; BONE MARROW DEPRESSION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COOMBS TEST; DELAYED DIAGNOSIS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINURIA; HEPATITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAUNDICE; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MEDICAL RECORD REVIEW; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RETICULOCYTOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SYMPTOM; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOSIS;

ADOLESCENT; ANEMIA; BONE MARROW; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINURIA, PAROXYSMAL; HEMOLYSIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; RETROSPECTIVE STUDIES; THROMBOSIS;

EID: 84862263225     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23410     Document Type: Article

References (13)

1. Ware RE, Hall SE, Rosse WF. Paroxysmal nocturnal hemoglobinuria with onset in childhood and adolescence. N Engl J Med 1991;325:991-996.
2. Hillmen P, et al. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995;333:1253-1258.
3. Socie G, et al. Paroxysmal nocturnal haemoglobinuria: Long-term follow-up and prognostic factors. French Society of Haematology. Lancet 1996;348:573-577.
4. Bessler M, Hiken J. The pathophysiology of disease in patients with paroxysmal nocturnal hemoglobinuria. Hematol Am Soc Hematol Educ Program 2008;2008:104-110.
5. van den Heuvel-Eibrink MM, et al. Childhood paroxysmal nocturnal haemoglobinuria (PNH), a report of 11 cases in the Netherlands. Br J Haematol 2005;128:571-577.
6. Nishimura J, et al. Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan. Medicine (Baltimore) 2004;83:193-207.
7. Parker C, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 2005;106:3699-3709.
8. Araten DJ, et al. Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria. Br J Haematol 2001;115:360-368.
9. Maciejewski JP, et al. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. Blood 2002;99:3129-3135.
10. Hall C, Richards S, Hillmen P. Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood 2003;102:3587-3591.
11. Araten DJ, Thaler HT, Luzzatto L. High incidence of thrombosis in African-American and Latin-American patients with paroxysmal nocturnal haemoglobinuria. Thromb Haemost 2005;93:88-91.
12. Hillmen P. The role of complement inhibition in PNH. Hematol Am Soc Hematol Educ Program 2008; 116-123.
13. Thomas TC, et al. Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. Mol Immunol, 1996;33:1389-1401.